Norcod AS (OSL:NCOD)
Norway · Delayed Price · Currency is NOK 12.90
+0.05 (0.39%)
Aug 1, 2025, 3:33 PM CET
Theseus Pharmaceuticals Revenue
Norcod AS had revenue of 193.45M NOK in the quarter ending March 31, 2025, with 63.30% growth. This brings the company's revenue in the last twelve months to 472.17M, up 79.68% year-over-year. In the year 2024, Norcod AS had annual revenue of 397.18M with 47.42% growth.
Revenue (ttm)
472.17M
Revenue Growth
+79.68%
P/S Ratio
1.57
Revenue / Employee
5.55M
Employees
86
Market Cap
743.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 397.18M | 127.76M | 47.42% |
| Dec 31, 2023 | 269.42M | 98.88M | 57.98% |
| Dec 31, 2022 | 170.54M | 97.91M | 134.80% |
| Dec 31, 2021 | 72.63M | 65.41M | 905.30% |
| Dec 31, 2020 | 7.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orkla ASA | 71.83B |
| Mowi ASA | 64.00B |
| SalMar ASA | 24.73B |
| Lerøy Seafood Group ASA | 31.97B |
| P/F Bakkafrost | 10.71B |
| Austevoll Seafood ASA | 36.79B |
| Europris ASA | 14.36B |
| Grieg Seafood ASA | 7.32B |